Golshah Amin, Mirzaeei Shahla, Nikkerdar Nafiseh, Ghorbani Fatemeh
Department of Orthodontic, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Int J Dent. 2021 Mar 29;2021:6615900. doi: 10.1155/2021/6615900. eCollection 2021.
Treatment of gingivitis in patients undergoing orthodontic treatment is done through different methods. Anti-inflammatory agents present in toothpaste or mouthwash are applied spontaneously by patients or used as professional treatment protocols. The present study aimed to investigate the gingivitis effectiveness of Emulgel containing 2% resveratrol in orthodontic patients.
The study was conducted in three groups, namely, experimental, placebo, and control. In the experimental group, participants used an Emulgel containing 2% resveratrol. In the placebo group, subjects used an identical Emulgel without the active components in the test formulations. After brushing their teeth, the participants learned how to use 5 ml of Emulgel on the gums and massage every night for 30 s. In the control group, subjects were instructed to massage their gums for 30 s every night without any product. Evaluated criteria included bleeding on probing (BOP), gingival index (GI), hyperplastic index (HI), and probing pocket depth (PPD).
During 4 and 8 weeks of the study, the PPD score in the control group did not change significantly but decreased in both groups. Also, there was a decrease in the PPD score in the experimental group compared to the placebo and control groups. Similarly, in the experimental group, continuous use of Emulgel containing 2% resveratrol reduced the HI and GI scores significantly at 4 and 8 weeks after the start of the study. Here, the decrease in GI and HI scores in the experimental group was higher than that of the other groups.
The Emulgel containing 2% resveratrol is effective in improving gingival health in orthodontic patients and can lower gingival inflammation over 8 weeks. This trial is registered with the Iranian registry of clinical trials (https://irct.ir/) IRCT20130812014333N91.
正畸治疗患者的牙龈炎治疗方法多样。牙膏或漱口水中的抗炎剂由患者自行使用,或作为专业治疗方案使用。本研究旨在调查含2%白藜芦醇的乳胶凝胶对正畸患者牙龈炎的治疗效果。
本研究分为三组,即实验组、安慰剂组和对照组。实验组参与者使用含2%白藜芦醇的乳胶凝胶。安慰剂组受试者使用不含测试配方中活性成分的相同乳胶凝胶。刷牙后,参与者学习如何每晚在牙龈上使用5毫升乳胶凝胶并按摩30秒。对照组受试者被指示每晚不使用任何产品,仅按摩牙龈30秒。评估标准包括探诊出血(BOP)、牙龈指数(GI)、增生指数(HI)和探诊袋深度(PPD)。
在研究的第4周和第8周,对照组的PPD评分无显著变化,而两组的PPD评分均下降。此外,与安慰剂组和对照组相比,实验组的PPD评分有所下降。同样,在实验组中,连续使用含2%白藜芦醇的乳胶凝胶在研究开始后的第4周和第8周显著降低了HI和GI评分。在此,实验组的GI和HI评分下降幅度高于其他组。
含2%白藜芦醇的乳胶凝胶对改善正畸患者的牙龈健康有效,且可在8周内减轻牙龈炎症。本试验已在伊朗临床试验注册中心(https://irct.ir/)注册,注册号为IRCT20130812014333N91。